Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab
Clinical trial NCT02304484 · COMPLETED
Trial details
- NCT number
- NCT02304484
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2018-03-09
- Enrollment
- 770
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.